The most common and widely accepted classification of breast cancer is from an immunohistochemical perspective, based on the expression of estrogen receptor (ER), progesterone receptor (PR), and overexpression of human epidermal growth factor receptor 2 (HER2), and/or amplification of ERBB2 gene. This evidence concerns the gene ESR1 and breast carcinoma.